These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2839866)

  • 1. Hepatic artery injection of I-131-labeled lipiodol. Part I. Biodistribution study results in patients with hepatocellular carcinoma and liver metastases.
    Raoul JL; Bourguet P; Bretagne JF; Duvauferrier R; Coornaert S; Darnault P; Ramée A; Herry JY; Gastard J
    Radiology; 1988 Aug; 168(2):541-5. PubMed ID: 2839866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic artery injection of I-131-labeled lipiodol. Part II. Preliminary results of therapeutic use in patients with hepatocellular carcinoma and liver metastases.
    Bretagne JF; Raoul JL; Bourguet P; Duvauferrier R; Deugnier Y; Faroux R; Ramée A; Herry JY; Gastard J
    Radiology; 1988 Aug; 168(2):547-50. PubMed ID: 2839867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lipiodol UltraFluid in the imaging diagnosis of hepatocarcinoma with cirrhosis].
    Roversi R; Ricci S; Rossi C; Gambari P; Galaverni MC; Teodorani A; Gardini G
    Radiol Med; 1989; 78(1-2):44-52. PubMed ID: 2550998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipiodolized angiography in hepatocellular carcinomas. Contribution of iodine-131-labelled lipiodol].
    Raoul JL; Duvauferrier R; Bourguet P; Bretagne JF; Coornaert S; Darnault P; Deugnier Y; Herry JY; Gastard J
    J Radiol; 1986 Nov; 67(11):797-801. PubMed ID: 3027321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodistribution and in vivo kinetics of iodine-131 lipiodol infused via the hepatic artery of patients with hepatic cancer.
    Nakajo M; Kobayashi H; Shimabukuro K; Shirono K; Sakata H; Taguchi M; Uchiyama N; Sonoda T; Shinohara S
    J Nucl Med; 1988 Jun; 29(6):1066-77. PubMed ID: 2836573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoembolization of hepatocellular carcinomas. A study of the biodistribution and pharmacokinetics of doxorubicin.
    Raoul JL; Heresbach D; Bretagne JF; Ferrer DB; Duvauferrier R; Bourguet P; Messner M; Gosselin M
    Cancer; 1992 Aug; 70(3):585-90. PubMed ID: 1320447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with
    Delaunay K; Edeline J; Rolland Y; Lepareur N; Laffont S; Palard X; Bouvry C; Le Sourd S; Pracht M; Ardisson V; Noiret N; Bellissant É; Garin E
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1506-1517. PubMed ID: 30715571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and biodistribution of 188Re-SSS lipiodol following injection into the hepatic artery of healthy pigs.
    Garin E; Noiret N; Malbert C; Lepareur N; Roucoux A; Caulet-Maugendre S; Moisan A; Lecloirec J; Herry JY; Bourguet P
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):542-6. PubMed ID: 14691613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution of Lipiodol following hepatic arterial injection.
    Hind RE; Loizidou M; Perring S; Fleming J; Batty V; Birch S; Taylor I
    Br J Surg; 1992 Sep; 79(9):952-4. PubMed ID: 1330198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of hepatic arterial phase CT versus lipiodol ultrafluid CT in the detection of hepatocellular carcinoma.
    Colagrande S; Fargnoli R; Dal Pozzo F; Bindi A; Rega L; Villari N
    J Comput Assist Tomogr; 2000; 24(6):878-83. PubMed ID: 11105704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitations of hyperselective intraarterial injections for the treatment of hepatocellular carcinoma.
    Raoul JL; Bretagne JF; Bourguet P; Duvauferrier R
    Invest Radiol; 1996 May; 31(5):305-7. PubMed ID: 8724131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of stabilized iodized oil emulsion on experimentally induced hepatocellular carcinoma in rats.
    Garin E; Denizot B; Roux J; Noiret N; Lepareur N; Moreau M; Mesba A; Laurent JF; Herry JY; Bourguet P; Benoit JP; Lejeune JJ
    J Vasc Interv Radiol; 2005 Jun; 16(6):841-8. PubMed ID: 15947048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of the kinetics of iodized oil injected into the feeding artery of hepatocellular carcinoma using dynamic computed tomography.
    Inoue H; Miyazono N; Miyake S; Nishida H; Kanetsuki I; Hori A; Mukai H; Ueno K; Nakajo M
    Radiat Med; 1994; 12(2):53-8. PubMed ID: 8079003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 131I thyroid uptake in patients treated with 131I-Lipiodol for hepatocellular carcinoma.
    Toubeau M; Touzery C; Berriolo-Riedinger A; Cochet A; Brunotte F; Bedenne L; Cercueil JP; Krause D
    Eur J Nucl Med; 2001 May; 28(5):669-70. PubMed ID: 11383874
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective and persistent deposition and gradual drainage of iodized oil, Lipiodol in the hepatocellular carcinoma after injection into the feeding hepatic artery.
    Okayasu I; Hatakeyama S; Yoshida T; Yoshimatsu S; Tsuruta K; Miyamoto H; Kimula Y
    Am J Clin Pathol; 1988 Nov; 90(5):536-44. PubMed ID: 2459957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The CT scan coupled to the injection of lipiodol into the hepatic artery. Preliminary trial].
    Bruneton JN; Grimaldi C; Kerboul P; Rampal P; Namer M; Bourry J; Delmont J
    Ann Gastroenterol Hepatol (Paris); 1985 Dec; 21(6):409-12. PubMed ID: 3006580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of Lipiodol in hepatocellular carcinoma.
    Park C; Choi SI; Kim H; Yoo HS; Lee YB
    Liver; 1990 Apr; 10(2):72-8. PubMed ID: 2161978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodistribution of lipiodol following hepatic arterial injection.
    Hind RE; Loizidou M; Fleming J; Batty V; Birch S; Taylor I
    Eur J Surg Oncol; 1992 Apr; 18(2):162-7. PubMed ID: 1316290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of hepatic artery injection of iodized oil and 131I-labeled iodized oil before the therapeutic decision in hepatocellular carcinoma.
    Raoul JL; Duvauferrier R; Bretagne JF; Bourguet P; Heresbach D; Siproudhis L; Gosselin M
    Scand J Gastroenterol; 1993 Mar; 28(3):217-23. PubMed ID: 7680489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nodular hepatocellular carcinoma--treatment with intraarterial injection of I-131 Lipiodol.
    Yoo HS; Suh JH; Lee JT; Kim KW; Kim DI; Kim BS; Choi HJ; Lee KS
    J Korean Med Sci; 1990 Jun; 5(2):75-83. PubMed ID: 2177607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.